BiondVax Pharmaceuticals Ltd. Sponsored ADR
(NASDAQ : BVXV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc.
0.07%55.210.6%$795.38m
JNJJohnson & Johnson
-0.63%137.990.6%$674.63m
ABBVAbbVie, Inc.
-0.90%93.622.1%$574.69m
PFEPfizer Inc.
-0.56%35.360.8%$547.67m
BMYBristol-Myers Squibb Company
-0.91%61.311.4%$343.78m
LLYEli Lilly and Company
-0.62%82.921.0%$273.08m
GSKGlaxoSmithKline plc Sponsored ADR
-0.38%35.060.2%$240.04m
NVSNovartis AG Sponsored ADR
1.13%83.960.2%$199.03m
AZNAstraZeneca PLC Sponsored ADR
-0.24%33.441.3%$108.49m
NVONovo Nordisk A/S Sponsored ADR Class B
0.80%50.910.1%$88.43m
SNYSanofi Sponsored ADR
-0.24%44.550.2%$62.16m
LCILannett Company, Inc.
0.00%23.9538.2%$17.13m
SCMPSucampo Pharmaceuticals, Inc. Class A
1.93%10.5514.4%$4.77m
AKTXAkari Therapeutics Plc Sponsored ADR
6.16%4.652.2%$0.95m
EPIXESSA Pharma Inc
0.00%0.270.0%$0.04m

Company Profile

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Ness Ziona, Israel.